Scientific Articles
2024
KCNQ1 suppression-replacement gene therapy in
transgenic rabbits with type 1 long QT syndrome
Vigorous Exercise in Patients With Congenital
Long-QT Syndrome: Results of the Prospective,
Observational, Multinational LIVE-LQTS Study
NaV1.5 autoantibodies in Brugada syndrome:
pathogenetic implications
PTSD After PerformingCPR: Steps to Healing and Recovery
Artificial intelligence-enhanced
electrocardiogram for arrhythmogenic right
ventricular cardiomyopathy detection
A novel tool for arrhythmic risk stratification
in desmoplakin gene variant carriers
Therapeutic Efficacy of Mexiletine for Long QT
Syndrome Type 2: Evidence From Human Induced
Pluripotent Stem Cell–Derived Cardiomyocytes,
Transgenic Rabbits, and Patients
SCN5A gene variants and arrhythmic risk in Brugada syndrome: An updated systematic review and meta-analysis
“What if it happensagain?” and Other Intrusive Thoughts
A Clinical Diagnostic Test for Calcium Release Deficiency Syndrome
Type 1 Brugada Pattern May Be Provoked by
Ajmaline in Some Healthy Subjects: Results
From a Clinical Trial
Energy drinks and sudden death: If it swims like a duck…
2024 HRS expert consensus statement on arrhythmias in the athlete: Evaluation,
treatment, and return to play
Sudden cardiac arrest occurring in temporal proximity to consumption of
energy drinks
Risk prediction in male adolescents with congenital long QT syndrome: Implications for sex‐specific risk stratification in potassium channel‐mediated long QT syndrome.
Disputation on the power and efficacy of phenotypical classification in arrhythmogenic cardiomyopathy: Time for a reformation?!
Kir2.1-nav1.5 channelosome and its role in arrhythmias in inheritable cardiac diseases.
Top stories on arrhythmias in tango2 deficiency disorder.
Long-term clinical outcomes of patients with drug-induced type 1 brugada electrocardiographic pattern: A nationwide cohort registry study.
Implantable loop recorders in patients with Brugada syndrome
Artificial Intelligence in Diagnosis of Long QT Syndrome A Review of Current State, Challenges, and Future Perspectives
Catecholaminergic Polymorphic Ventricular Tachycardia: Multiple Clinical Presentations of a Genetically Determined Disease
Top Stories on Gene Therapy for Genetic Heart Conditions
Top stories in Wolff-Parkinson-White syndrome
Top stories on congenital long QT syndrome
How Much Do Physicians Really Know About FDA Drug and Device Regulation?
AAV-Mediated Delivery of Plakophilin-2a Arrests Progression of Arrhythmogenic Right Ventricular
Cardiomyopathy in Murine Hearts: Preclinical
Evidence Supporting Gene Therapy in Humans
The Kir2.1 1 E299V mutation increases atrial fibrillation vulnerability 2 while protecting the ventricles against arrhythmias in a mouse 3 model of Short QT Syndrome type 3
Characterizing Decision-Making Surrounding Exercise in ARVC: Analysis of Decisional Conflict, Decisional Regret, and Shared Decision-Making
Is right ventricular outflow tract epicardial substrate ablation the standard of care in high-risk Brugada syndrome?
Genetically Elusive Long QT Syndrome
Promoter Deletion Confirms That MYBPC3 Haploinsufficiency Is Sufficient to Cause Hypertrophic Cardiomyopathy in Humans
2023
Top stories on Brugada syndrome
Sudden Cardiac Death in National Collegiate
Athletic Association Athletes: A 20-Year Study
Application and Validation of Phenotype-Enhanced Variant Classification in East Asian Patients with Catecholaminergic Polymorphic Ventricular Tachycardia
Effects of cohort, genotype, variant, and
maternal β-blocker treatment on foetal heart
rate predictors of inherited long QT syndrome
Clinical Management of Brugada Syndrome:
Commentary From the Experts
Mindfulness-based Intervention Shows Promise for PTSD in Cardiac Arrest Survivors
November 15 2023
SUMMARY FDA CBER OTAT Patient-Focused Drug Development Listening Meeting – Patient Perspectives on Gene Therapy Products
Flecainide Is Associated With a Lower Incidence
of Arrhythmic Events in a Large Cohort of
Patients With Catecholaminergic Polymorphic
Ventricular Tachycardia
From gene-discovery to gene-tailored clinical
management: 25 years of research in
channelopathies and cardiomyopathies
Asymptomatic Patients With Brugada ECG
Pattern: Long-Term Prognosis From a Large
Prospective Study
Medtronic receives FDA approval for extravascular defibrillator to treat abnormal heart rhythms, sudden cardiac arrest
2023 ESC Guidelines for the management of cardiomyopathies
The 2023 Canadian Cardiovascular Society Clinical Practice Update on Management of the Patient With a Prolonged QT Interval
MRI imaging in pediatric patients with ICDs
Association Between Syncope Trigger Type and Risk of Subsequent
Life-Threatening Events in Patients With Long QT Syndrome
July 2023
Use, misuse, and pitfalls of the drug challenge test in the diagnosis of the Brugada syndrome
July 2023
Long-Term Outcomes of Brugada Substrate Ablation: A Report from BRAVO (Brugada Ablation of VF Substrate Ongoing Multicenter Registry)
July 2023
Treatment Strategies for Cardiomyopathy in Children: A Scientific Statement From the American Heart Association
A graphene “tattoo” could help hearts keep their beat
In vivo KCNQ1-suppression-replacement gene therapy in transgenic rabbits with type 1
long QT syndrome
High-power chargers for electric vehicles:
are they safe for patients with pacemakers
and defibrillators?
Diagnostic pitfalls in patients referred for arrhythmogenic right ventricular cardiomyopathy
Blinded, randomized trial of sonographer
versus AI cardiac function assessment
Value of genetic testing in the diagnosis and risk stratification of arrhythmogenic right ventricular cardiomyopathy
SGK1 Inhibition Attenuated the Action Potential Duration in Patient- and Genotype-Specific Re-Engineered Heart Cells with Congenital Long QT Syndrome
Longitudinal assessment of structural phenotype in Brugada syndrome using cardiac magnetic resonance imaging
The Genetics of Brugada Syndrome
2022
Phenotypes of Overdiagnosed Long QT Syndrome
Suppression and Replacement Gene Therapy for KCNH2-Mediated Arrhythmias
Posttraumatic stress disorder in pediatric patients with implantable cardioverter-defibrillators and their parents
International Evidence Based Reappraisal of Genes Associated with ARVC
Life-threatening cardiac arrhythmia and sudden death during electronic gaming
Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
Does sports participation increase risk in patients with long QT syndrome? Results from a large French cohort
A prospective longitudinal study of health-related quality of life and psychological wellbeing after an implantable cardioverter-defibrillator (ICD) in patients with genetic heart diseases
Use of oral contraceptives in women with congenital long QT syndrome
EDITORIAL COMMENTARY Oral contraceptives and their effect on arrhythmogenesis in long QT syndrome: Does it matter?
Burst Exercise Testing Can Unmask Arrhythmias in Patients With Incompletely Penetrant Catecholaminergic Polymorphic Ventricular (CPVT)
Outcomes of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) Treated With β-Blockers
Experiences of athletes with arrhythmogenic cardiac conditions (SADS) in returning to play
Diagnosis and management of rare cardiomyopathies in adult and paediatric patients: the ACM Team
An International Multicenter Study on β-Blockers for the Treatment of Symptomatic Children with CPVT
Brugada Syndrome: State-of-the-Art Review Abstract
Heart transplantation outcomes in arrhythmogenic right ventricular cardiomyopathy: a contemporary national analysis
Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility
Recent understanding of clinical sequencing and gene-based risk stratification in inherited primary arrhythmia syndrome
Clinical characteristics and risk stratification of desmoplakin cardiomyopathy
A prospective longitudinal study of health-related quality of life and psychological wellbeing after an implantable cardioverter-defibrillator (ICD) in patients with genetic heart diseases
Genome Sequencing in a Genetically Elusive Multi-Generational Long QT Syndrome Pedigree Identifies a Novel LQT2-Causative Deeply Intronic KCNH2 Variant
Diagnostic accuracy of the 12-lead ECG in the first 48 hours of life for newborns of a parent with congenital long QT syndrome
Psychosocial symptoms of ventricular arrhythmias: Integrating patient-reported outcomes in to clinical care
Psychosocial-symptoms-of-ventricular-arrhythmiasHRS2022.pdf
Multimodality Imaging in Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
2021
Re-Entry Anxiety in the Pandemic Aftermath
Importance of Dedicated Units for Management of SADS CircGen April 2021
2020 APHRS/HRS expert consensus statement on the investigation of decedents with sudden unexplained death and patients with sudden cardiac arrest, and of their families
KKCNQ1 Gene Therapy for LQT1 CIRCULATIONAHA.1-28-21
Life Saving Therapy Inhibition by Phones Containing Magnets
2020
An autoantibody identifies arrhythmogenic right ventricular cardiomyopathy and participates in its pathogenesis
An autoantibody profile detects Brugada syndrome and identifies abnormally expressedmyocardial proteins
Wash U-developed holograms help physicians during cardiac procedure
Validation and Disease Risk Assessment of Previously Reported Genome-Wide Genetic Variants Associated with Brugada Syndrome: SADS-TW BrS Registry
An International Multicenter Evaluation of Type 5 Long QT Syndrome
An International, Multicentered, Evidence-Based Reappraisal of Genes Reported to Cause Congenital Long QT Syndrome
Circulation: Arrhythmia and Electrophysiology:Heart Rate Recovery After Exercise Is Associated With Arrhythmic Events in Patients With Catecholaminergic Polymorphic Ventricular Tachycardia
CIRCEP Heart Rate Recovery After Exercise in CPVT
Genetic Testing in Inherited Heart Diseases
Genetic Cardiovascular Conditions – It’s All About Family
Exercise and Arrhythmogenic Right Ventricular Cardiomyopathy
Brugada Syndrome: Clinical Care Amidst Pathophysiological Uncertainty
Pre-Test Probability and Genes and VUS’s in Familial LQTS
50 Years of Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
ACC.20 Together with World Congress of Cardiology
Precision medicine opportunities for familial arrhythmias and cardiomyopathies identified when cost of genetic testing is removed as a barrier
A Novel Genotype -Phenotype Risk Prediction Model for Arrhythmic Events in Women with Long-QT Syndrome
Clinical limitations of genotyping- versus sequencing-based strategies for cardiomyopathy evaluation
Exertional syncope in with college varsity athletes
Implantable Cardioverter Defibrillator placement in a patient with potentially reversible causes of Long QT Syndrome
Left Cardiac Sympathectomy Denervation LQTS
MEXILETINE Shortens QT Interval
Outcomes of Sports Participation for Patients with Hypertrophic Cardiomyopathy and Implantable Cardioverter: Data from the ICD Sportys Regisrty
QTc in Patients with Turner Syndrome
AED Resources
CPR & AED Awareness Kit
2022
2024
KCNQ1 suppression-replacement gene therapy in
transgenic rabbits with type 1 long QT syndrome
Vigorous Exercise in Patients With Congenital
Long-QT Syndrome: Results of the Prospective,
Observational, Multinational LIVE-LQTS Study
NaV1.5 autoantibodies in Brugada syndrome:
pathogenetic implications
PTSD After PerformingCPR: Steps to Healing and Recovery
Artificial intelligence-enhanced
electrocardiogram for arrhythmogenic right
ventricular cardiomyopathy detection
A novel tool for arrhythmic risk stratification
in desmoplakin gene variant carriers
Therapeutic Efficacy of Mexiletine for Long QT
Syndrome Type 2: Evidence From Human Induced
Pluripotent Stem Cell–Derived Cardiomyocytes,
Transgenic Rabbits, and Patients
SCN5A gene variants and arrhythmic risk in Brugada syndrome: An updated systematic review and meta-analysis
“What if it happensagain?” and Other Intrusive Thoughts
A Clinical Diagnostic Test for Calcium Release Deficiency Syndrome
Type 1 Brugada Pattern May Be Provoked by
Ajmaline in Some Healthy Subjects: Results
From a Clinical Trial
Energy drinks and sudden death: If it swims like a duck…
2024 HRS expert consensus statement on arrhythmias in the athlete: Evaluation,
treatment, and return to play
Sudden cardiac arrest occurring in temporal proximity to consumption of
energy drinks
Risk prediction in male adolescents with congenital long QT syndrome: Implications for sex‐specific risk stratification in potassium channel‐mediated long QT syndrome.
Disputation on the power and efficacy of phenotypical classification in arrhythmogenic cardiomyopathy: Time for a reformation?!
Kir2.1-nav1.5 channelosome and its role in arrhythmias in inheritable cardiac diseases.
Top stories on arrhythmias in tango2 deficiency disorder.
Long-term clinical outcomes of patients with drug-induced type 1 brugada electrocardiographic pattern: A nationwide cohort registry study.
Implantable loop recorders in patients with Brugada syndrome
Artificial Intelligence in Diagnosis of Long QT Syndrome A Review of Current State, Challenges, and Future Perspectives
Catecholaminergic Polymorphic Ventricular Tachycardia: Multiple Clinical Presentations of a Genetically Determined Disease
Top Stories on Gene Therapy for Genetic Heart Conditions
Top stories in Wolff-Parkinson-White syndrome
Top stories on congenital long QT syndrome
How Much Do Physicians Really Know About FDA Drug and Device Regulation?
AAV-Mediated Delivery of Plakophilin-2a Arrests Progression of Arrhythmogenic Right Ventricular
Cardiomyopathy in Murine Hearts: Preclinical
Evidence Supporting Gene Therapy in Humans
The Kir2.1 1 E299V mutation increases atrial fibrillation vulnerability 2 while protecting the ventricles against arrhythmias in a mouse 3 model of Short QT Syndrome type 3
Characterizing Decision-Making Surrounding Exercise in ARVC: Analysis of Decisional Conflict, Decisional Regret, and Shared Decision-Making
Is right ventricular outflow tract epicardial substrate ablation the standard of care in high-risk Brugada syndrome?
Genetically Elusive Long QT Syndrome
Promoter Deletion Confirms That MYBPC3 Haploinsufficiency Is Sufficient to Cause Hypertrophic Cardiomyopathy in Humans
2023
Top stories on Brugada syndrome
Sudden Cardiac Death in National Collegiate
Athletic Association Athletes: A 20-Year Study
Application and Validation of Phenotype-Enhanced Variant Classification in East Asian Patients with Catecholaminergic Polymorphic Ventricular Tachycardia
Effects of cohort, genotype, variant, and
maternal β-blocker treatment on foetal heart
rate predictors of inherited long QT syndrome
Clinical Management of Brugada Syndrome:
Commentary From the Experts
Mindfulness-based Intervention Shows Promise for PTSD in Cardiac Arrest Survivors
November 15 2023
SUMMARY FDA CBER OTAT Patient-Focused Drug Development Listening Meeting – Patient Perspectives on Gene Therapy Products
Flecainide Is Associated With a Lower Incidence
of Arrhythmic Events in a Large Cohort of
Patients With Catecholaminergic Polymorphic
Ventricular Tachycardia
From gene-discovery to gene-tailored clinical
management: 25 years of research in
channelopathies and cardiomyopathies
Asymptomatic Patients With Brugada ECG
Pattern: Long-Term Prognosis From a Large
Prospective Study
Medtronic receives FDA approval for extravascular defibrillator to treat abnormal heart rhythms, sudden cardiac arrest
2023 ESC Guidelines for the management of cardiomyopathies
The 2023 Canadian Cardiovascular Society Clinical Practice Update on Management of the Patient With a Prolonged QT Interval
MRI imaging in pediatric patients with ICDs
Association Between Syncope Trigger Type and Risk of Subsequent
Life-Threatening Events in Patients With Long QT Syndrome
July 2023
Use, misuse, and pitfalls of the drug challenge test in the diagnosis of the Brugada syndrome
July 2023
Long-Term Outcomes of Brugada Substrate Ablation: A Report from BRAVO (Brugada Ablation of VF Substrate Ongoing Multicenter Registry)
July 2023
Treatment Strategies for Cardiomyopathy in Children: A Scientific Statement From the American Heart Association
A graphene “tattoo” could help hearts keep their beat
In vivo KCNQ1-suppression-replacement gene therapy in transgenic rabbits with type 1
long QT syndrome
High-power chargers for electric vehicles:
are they safe for patients with pacemakers
and defibrillators?
Diagnostic pitfalls in patients referred for arrhythmogenic right ventricular cardiomyopathy
Blinded, randomized trial of sonographer
versus AI cardiac function assessment
Value of genetic testing in the diagnosis and risk stratification of arrhythmogenic right ventricular cardiomyopathy
SGK1 Inhibition Attenuated the Action Potential Duration in Patient- and Genotype-Specific Re-Engineered Heart Cells with Congenital Long QT Syndrome
Longitudinal assessment of structural phenotype in Brugada syndrome using cardiac magnetic resonance imaging
The Genetics of Brugada Syndrome
2022
Phenotypes of Overdiagnosed Long QT Syndrome
Suppression and Replacement Gene Therapy for KCNH2-Mediated Arrhythmias
Posttraumatic stress disorder in pediatric patients with implantable cardioverter-defibrillators and their parents
International Evidence Based Reappraisal of Genes Associated with ARVC
Life-threatening cardiac arrhythmia and sudden death during electronic gaming
Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
Does sports participation increase risk in patients with long QT syndrome? Results from a large French cohort
A prospective longitudinal study of health-related quality of life and psychological wellbeing after an implantable cardioverter-defibrillator (ICD) in patients with genetic heart diseases
Use of oral contraceptives in women with congenital long QT syndrome
EDITORIAL COMMENTARY Oral contraceptives and their effect on arrhythmogenesis in long QT syndrome: Does it matter?
Burst Exercise Testing Can Unmask Arrhythmias in Patients With Incompletely Penetrant Catecholaminergic Polymorphic Ventricular (CPVT)
Outcomes of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) Treated With β-Blockers
Experiences of athletes with arrhythmogenic cardiac conditions (SADS) in returning to play
Diagnosis and management of rare cardiomyopathies in adult and paediatric patients: the ACM Team
An International Multicenter Study on β-Blockers for the Treatment of Symptomatic Children with CPVT
Brugada Syndrome: State-of-the-Art Review Abstract
Heart transplantation outcomes in arrhythmogenic right ventricular cardiomyopathy: a contemporary national analysis
Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility
Recent understanding of clinical sequencing and gene-based risk stratification in inherited primary arrhythmia syndrome
Clinical characteristics and risk stratification of desmoplakin cardiomyopathy
A prospective longitudinal study of health-related quality of life and psychological wellbeing after an implantable cardioverter-defibrillator (ICD) in patients with genetic heart diseases
Genome Sequencing in a Genetically Elusive Multi-Generational Long QT Syndrome Pedigree Identifies a Novel LQT2-Causative Deeply Intronic KCNH2 Variant
Diagnostic accuracy of the 12-lead ECG in the first 48 hours of life for newborns of a parent with congenital long QT syndrome
Psychosocial symptoms of ventricular arrhythmias: Integrating patient-reported outcomes in to clinical care
Psychosocial-symptoms-of-ventricular-arrhythmiasHRS2022.pdf
Multimodality Imaging in Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
2021
Re-Entry Anxiety in the Pandemic Aftermath
Importance of Dedicated Units for Management of SADS CircGen April 2021
2020 APHRS/HRS expert consensus statement on the investigation of decedents with sudden unexplained death and patients with sudden cardiac arrest, and of their families
KKCNQ1 Gene Therapy for LQT1 CIRCULATIONAHA.1-28-21
Life Saving Therapy Inhibition by Phones Containing Magnets
2020
An autoantibody identifies arrhythmogenic right ventricular cardiomyopathy and participates in its pathogenesis
An autoantibody profile detects Brugada syndrome and identifies abnormally expressedmyocardial proteins
Wash U-developed holograms help physicians during cardiac procedure
Validation and Disease Risk Assessment of Previously Reported Genome-Wide Genetic Variants Associated with Brugada Syndrome: SADS-TW BrS Registry
An International Multicenter Evaluation of Type 5 Long QT Syndrome
An International, Multicentered, Evidence-Based Reappraisal of Genes Reported to Cause Congenital Long QT Syndrome
Circulation: Arrhythmia and Electrophysiology:Heart Rate Recovery After Exercise Is Associated With Arrhythmic Events in Patients With Catecholaminergic Polymorphic Ventricular Tachycardia
CIRCEP Heart Rate Recovery After Exercise in CPVT
Genetic Testing in Inherited Heart Diseases
Genetic Cardiovascular Conditions – It’s All About Family
Exercise and Arrhythmogenic Right Ventricular Cardiomyopathy
Brugada Syndrome: Clinical Care Amidst Pathophysiological Uncertainty
Pre-Test Probability and Genes and VUS’s in Familial LQTS
50 Years of Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
ACC.20 Together with World Congress of Cardiology
Precision medicine opportunities for familial arrhythmias and cardiomyopathies identified when cost of genetic testing is removed as a barrier
A Novel Genotype -Phenotype Risk Prediction Model for Arrhythmic Events in Women with Long-QT Syndrome
Clinical limitations of genotyping- versus sequencing-based strategies for cardiomyopathy evaluation
Exertional syncope in with college varsity athletes
Implantable Cardioverter Defibrillator placement in a patient with potentially reversible causes of Long QT Syndrome
Left Cardiac Sympathectomy Denervation LQTS
MEXILETINE Shortens QT Interval
Outcomes of Sports Participation for Patients with Hypertrophic Cardiomyopathy and Implantable Cardioverter: Data from the ICD Sportys Regisrty
QTc in Patients with Turner Syndrome
Outcomes of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) Treated With β-Blockers
Suppression and Replacement Gene Therapy for KCNH2-Mediated Arrhythmias
Posttraumatic stress disorder in pediatric patients with implantable cardioverter-defibrillators and their parents
International Evidence Based Reappraisal of Genes Associated with ARVC
Life-threatening cardiac arrhythmia and sudden death during electronic gaming
Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
Does sports participation increase risk in patients with long QT syndrome? Results from a large French cohort
A prospective longitudinal study of health-related quality of life and psychological wellbeing after an implantable cardioverter-defibrillator (ICD) in patients with genetic heart diseases
Use of oral contraceptives in women with congenital long QT syndrome
EDITORIAL COMMENTARY Oral contraceptives and their effect on arrhythmogenesis in long QT syndrome: Does it matter?
Burst Exercise Testing Can Unmask Arrhythmias in Patients With Incompletely Penetrant Catecholaminergic Polymorphic Ventricular (CPVT)
Outcomes of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) Treated With β-Blockers
Experiences of athletes with arrhythmogenic cardiac conditions (SADS) in returning to play
Diagnosis and management of rare cardiomyopathies in adult and paediatric patients: the ACM Team
An International Multicenter Study on β-Blockers for the Treatment of Symptomatic Children with CPVT
Brugada Syndrome: State-of-the-Art Review Abstract
Heart transplantation outcomes in arrhythmogenic right ventricular cardiomyopathy: a contemporary national analysis
Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility
Recent understanding of clinical sequencing and gene-based risk stratification in inherited primary arrhythmia syndrome
Clinical characteristics and risk stratification of desmoplakin cardiomyopathy
A prospective longitudinal study of health-related quality of life and psychological wellbeing after an implantable cardioverter-defibrillator (ICD) in patients with genetic heart diseases
Genome Sequencing in a Genetically Elusive Multi-Generational Long QT Syndrome Pedigree Identifies a Novel LQT2-Causative Deeply Intronic KCNH2 Variant
Diagnostic accuracy of the 12-lead ECG in the first 48 hours of life for newborns of a parent with congenital long QT syndrome
Psychosocial symptoms of ventricular arrhythmias: Integrating patient-reported outcomes in to clinical care
Role of CACNA1C in Brugada syndrome: Prevalence and phenotype of probands referred for genetic testing
Multimodality Imaging in Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
2021
Re-Entry Anxiety in the Pandemic Aftermath
Importance of Dedicated Units for Management of SADS CircGen April 2021
2020 APHRS/HRS expert consensus statement on the investigation of decedents with sudden unexplained death and patients with sudden cardiac arrest, and of their families
KKCNQ1 Gene Therapy for LQT1 CIRCULATIONAHA.1-28-21
Life Saving Therapy Inhibition by Phones Containing Magnets
2020
An autoantibody identifies arrhythmogenic right ventricular cardiomyopathy and participates in its pathogenesis
An autoantibody profile detects Brugada syndrome and identifies abnormally expressedmyocardial proteins
Wash U-developed holograms help physicians during cardiac procedure
Validation and Disease Risk Assessment of Previously Reported Genome-Wide Genetic Variants Associated with Brugada Syndrome: SADS-TW BrS Registry
An International Multicenter Evaluation of Type 5 Long QT Syndrome
An International, Multicentered, Evidence-Based Reappraisal of Genes Reported to Cause Congenital Long QT Syndrome
Circulation: Arrhythmia and Electrophysiology:Heart Rate Recovery After Exercise Is Associated With Arrhythmic Events in Patients With Catecholaminergic Polymorphic Ventricular Tachycardia
CIRCEP Heart Rate Recovery After Exercise in CPVT
Genetic Testing in Inherited Heart Diseases
Genetic Cardiovascular Conditions – It’s All About Family
Exercise and Arrhythmogenic Right Ventricular Cardiomyopathy
Brugada Syndrome: Clinical Care Amidst Pathophysiological Uncertainty
Pre-Test Probability and Genes and VUS’s in Familial LQTS
50 Years of Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
Precision medicine opportunities for familial arrhythmias and cardiomyopathies identified when cost of genetic testing is removed as a barrier
A Novel Genotype -Phenotype Risk Prediction Model for Arrhythmic Events in Women with Long-QT Syndrome
Clinical limitations of genotyping- versus sequencing-based strategies for cardiomyopathy evaluation
Exertional syncope in with college varsity athletes
Implantable Cardioverter Defibrillator placement in a patient with potentially reversible causes of Long QT Syndrome
Left Cardiac Sympathectomy Denervation LQTS
MEXILETINE Shortens QT Interval
Outcomes of Sports Participation for Patients with Hypertrophic Cardiomyopathy and Implantable Cardioverter: Data from the ICD Sportys Regisrty
QTc in Patients with Turner Syndrome
AED Resources
CPR & AED Awareness Kit